Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02329951 · ClinicalTrials.gov registry record

Predictive Factors for LBP Interventional Treatment Outcomes

A clinical trial of Low Back Pain and Lumbar Radiculopathy, sponsored by Johns Hopkins University.

Completed
Registry status
346
Enrollment target
1
Study location

NCT02329951: Completed study of Low Back Pain and Lumbar Radiculopathy, sponsored by Johns Hopkins University.

NCT02329951 is a study of Low Back Pain and Lumbar Radiculopathy that has completed, run by Johns Hopkins University. The registered enrollment target is 346 participants, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02329951, a study of Low Back Pain and Lumbar Radiculopathy, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
346 participants
Enrollment target
1
Study location

Study Summary

In this study, we are attempting to determine which factors are associated with interventional treatment outcome for LBP (and to what extent). Up to 346 patients with LBP who are considered to be good candidates for therapeutic interventional procedures will be given a complete history and physical exam, which includes the assessment of Waddell signs, and querying them regarding factors shown in non-interventional studies or retrospective studies evaluating interventional treatments to be associated with negative treatment outcomes. These factors include the presence of Waddell and other physical exam signs, opioid use, allergies, psychopathology, concomitant pain conditions, a 6-point Likert scale on expectations, sleep abnormalities, secondary gain (e.g. medical board or litigation), procedure-related pain including from a 1 ml standardized injection, obesity, and smoking history. They will then proceed to undergo their scheduled intervention, which will be limited to epidural steroid injections (ESI), facet blocks and if positive, radiofrequency denervation, and sacroiliac (SI) joint injections. A positive outcome will be defined as 2-point or greater decrease in average pain score at 1-month and a score of \> 3 on a 1-5 Likert satisfaction scale. Those with a positive outcome at 1-month will remain in the study and be followed again at 3-months.

Primary Outcome

0-10 numerical rating scale for leg pain (ESI) or low back pain (facet procedure or sacroiliac joint injection). Higher scores indicate more pain.

Interventions

  • PROCEDURE Facet intervention
  • PROCEDURE Sacroiliac joint injection
  • PROCEDURE Epidural steroid injection

Study Locations (1)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 346 participants
Start Date 2014-12
Est. Completion 2021-12
Johns Hopkins University

1,448 total trials

What the finished NCT02329951 record still lists

NCT02329951 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap, below the 501-participant average among 122 other Low Back Pain trials with a reported enrollment target (31% lower).

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 3 interventions - of which Facet intervention is the first listed.

NCT02329951 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02329951 about?

NCT02329951 is a clinical study titled "Predictive Factors for LBP Interventional Treatment Outcomes". In this study, we are attempting to determine which factors are associated with interventional treatment outcome for LBP (and to what extent). Up to 346 patients with LBP who are considered to be good candidates for therapeutic interventional procedures will be given a complete history and physical ...

What is the current status of trial NCT02329951?

This trial is currently completed. The enrollment target is 346 participants. The study started on 2014-12. Estimated completion is 2021-12.

What conditions does trial NCT02329951 study?

This clinical trial studies the following conditions: Low Back Pain, Lumbar Radiculopathy.

What interventions are being tested in trial NCT02329951?

The interventions under investigation include: Facet intervention (PROCEDURE), Sacroiliac joint injection (PROCEDURE), Epidural steroid injection (PROCEDURE).

Who is sponsoring clinical trial NCT02329951?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02329951 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02329951's enrollment target sits among peer trials

346 20th of 122 higher than 103 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05267886 · 346 participants · Phase 4

    CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock

  • NCT06705842 · 346 participants · Phase 4

    APPI-Cost Trial for Perforated Appendicitis

  • NCT06932887 · 346 participants · Phase 3

    The Beat Pain Better Trial

  • NCT01742143 · 347 participants

    Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02329951, the US trial registry maintained by the National Library of Medicine. NCT02329951 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.